Moors & Cabot Inc. increased its position in UnitedHealth Group Inc (NYSE:UNH) by 12.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,900 shares of the healthcare conglomerate’s stock after buying an additional 316 shares during the period. Moors & Cabot Inc.’s holdings in UnitedHealth Group were worth $567,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Capital International Investors raised its position in UnitedHealth Group by 399.3% during the third quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after purchasing an additional 3,304,902 shares during the period. Jennison Associates LLC raised its position in UnitedHealth Group by 146.0% during the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after purchasing an additional 3,289,470 shares during the period. Janus Henderson Group PLC raised its position in UnitedHealth Group by 1,820.1% during the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after purchasing an additional 2,264,242 shares during the period. Vanguard Group Inc. raised its position in UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. Finally, Parametric Portfolio Associates LLC raised its position in UnitedHealth Group by 77.3% during the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after purchasing an additional 1,562,661 shares during the period. Institutional investors own 86.24% of the company’s stock.

UnitedHealth Group Inc (NYSE UNH) opened at $220.96 on Friday. UnitedHealth Group Inc has a 52 week low of $156.49 and a 52 week high of $250.79. The stock has a market capitalization of $218,580.00, a P/E ratio of 20.63, a P/E/G ratio of 1.26 and a beta of 0.70. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. During the same quarter in the prior year, the firm earned $2.11 earnings per share. UnitedHealth Group’s revenue was up 9.5% compared to the same quarter last year. analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current year.

A number of equities research analysts have issued reports on UNH shares. Cantor Fitzgerald restated a “buy” rating and set a $225.00 price objective on shares of UnitedHealth Group in a research report on Monday, November 27th. Piper Jaffray Companies upped their price objective on UnitedHealth Group to $228.00 and gave the company an “overweight” rating in a research report on Tuesday, October 17th. Jefferies Group restated a “buy” rating and set a $248.00 price objective on shares of UnitedHealth Group in a research report on Friday, December 1st. Deutsche Bank upped their price objective on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Finally, Credit Suisse Group began coverage on UnitedHealth Group in a research report on Thursday, November 2nd. They set an “outperform” rating and a $233.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $243.22.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the sale, the chief executive officer now owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. In the last three months, insiders sold 53,853 shares of company stock worth $12,358,508. 0.89% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: This piece was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://theolympiareport.com/2018/02/11/unitedhealth-group-inc-unh-shares-bought-by-moors-cabot-inc.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.